Literature DB >> 8999813

Cloning of an Apobec-1-binding protein that also interacts with apolipoprotein B mRNA and evidence for its involvement in RNA editing.

P P Lau1, H J Zhu, M Nakamuta, L Chan.   

Abstract

Apolipoprotein (apo)B mRNA editing is mediated by a multiprotein editosome complex. Apobec-1 is the catalytic component of this complex, but other proteins involved in editing have not been identified. We used the yeast two-hybrid system to identify an apobec-1-interacting protein, ABBP-1. ABBP-1 contains 331 amino acid residues and is identical to a previously reported human type A/B hnRNP except for a 47-residue insertion at its C-terminal region. It contains typical RNP motifs at its N-terminal half and glycine-rich motifs in the C-terminal region. Northern blot analysis indicates that ABBP-1 mRNA is distributed in multiple human tissues. By deletion analysis, we mapped the apobec-1-binding region to the glycine-rich domain. ABBP-1 also binds to apoB mRNA transcripts around the editing site and can be UV-cross-linked to them in vitro. Immnodepletion of ABBP-1 from an active apoB mRNA editing tissue extract inhibits its editing activity. Down-regulation of ABBP-1 in an apobec-1-expressing HepG2 cell line by transfection with an antisense ABBP-1 cDNA construct leads to inhibition of endogenous apoB mRNA editing. We conclude that ABBP-1 is an apobec-1-interacting protein that may play an important role in apoB mRNA editing.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8999813     DOI: 10.1074/jbc.272.3.1452

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Repression of the defense gene PR-10a by the single-stranded DNA binding protein SEBF.

Authors:  B Boyle; N Brisson
Journal:  Plant Cell       Date:  2001-11       Impact factor: 11.277

2.  Nuclear actin is associated with a specific subset of hnRNP A/B-type proteins.

Authors:  Piergiorgio Percipalle; Andreas Jonsson; Dmitri Nashchekin; Christina Karlsson; Tomas Bergman; Apostolia Guialis; Bertil Daneholt
Journal:  Nucleic Acids Res       Date:  2002-04-15       Impact factor: 16.971

3.  Genetic and hormonal control of hepatic steatosis in female and male mice.

Authors:  Frode Norheim; Simon T Hui; Emre Kulahcioglu; Margarete Mehrabian; Rita M Cantor; Calvin Pan; Brian W Parks; Aldons J Lusis
Journal:  J Lipid Res       Date:  2016-11-03       Impact factor: 5.922

4.  Functional requirements of AID's higher order structures and their interaction with RNA-binding proteins.

Authors:  Samiran Mondal; Nasim A Begum; Wenjun Hu; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

5.  An AU-rich sequence element (UUUN[A/U]U) downstream of the edited C in apolipoprotein B mRNA is a high-affinity binding site for Apobec-1: binding of Apobec-1 to this motif in the 3' untranslated region of c-myc increases mRNA stability.

Authors:  S Anant; N O Davidson
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

6.  Re-editing the paradigm of Cytidine (C) to Uridine (U) RNA editing.

Authors:  Nicolas Fossat; Patrick P L Tam
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

7.  Phosphorylation is a regulatory mechanism in apolipoprotein B mRNA editing.

Authors:  Z Chen; T L Eggerman; A P Patterson
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

8.  Regulation of alternative splicing within the supraspliceosome.

Authors:  Naama Sebbag-Sznajder; Oleg Raitskin; Minna Angenitzki; Taka-Aki Sato; Joseph Sperling; Ruth Sperling
Journal:  J Struct Biol       Date:  2011-11-12       Impact factor: 2.867

9.  Identification of the yeast cytidine deaminase CDD1 as an orphan C-->U RNA editase.

Authors:  G S Dance; P Beemiller; Y Yang; D V Mater; I S Mian; H C Smith
Journal:  Nucleic Acids Res       Date:  2001-04-15       Impact factor: 16.971

10.  cis Recognition elements in plant mitochondrion RNA editing.

Authors:  J C Farré; G Leon; X Jordana; A Araya
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.